Research Site

Seongbuk-Gu 2841

2 studies enrolling now · 4 studies all time

What they study most

Advanced or Metastatic Non-small Cell Lung Cancer, Breast Cancer, Early Breast Cancer, Diabetic Kidney Disease, ER-Positive HER2-Negative Breast Cancer

Studies at this site

• A Platform Study in Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• A Study of Camizestrant in ER+/HER2- Early Breast Cancer After at Least 2 Years of Standard Adjuvant Endocrine Therapy — Recruiting now
• A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer — Recruiting now
• A Phase 2b Diabetic Kidney Disease Study — Completed